Live Breaking News & Updates on Arker therapeutics
Stay updated with breaking news from Arker therapeutics . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Marker Therapeutics, Inc. (MRKR) rose by 23% on Monday after the company announced a clinical update concerning the APOLLO study, with the study participant tolerating the initial dose level well and remaining in complete response six months after MT-601 treatment MRKR is trading on the Nasdaq at $4.